Abstract
Background: The effects of the antihypertensive therapy with amlodipine (5-10 mg/day) on left ventricular mass and diastolic function were examined in 30 mild to moderate essential hypertensive patients who have left ventricular hypertrophy (LVH) and diastolic dysfunction.
Methods and Results: Each patient's left ventricular mass was measured, and left ventricular diastolic function was assessed by echocardiographic Doppler examination at entry, and at 3 and 6 months after the initiation of the treatment. Amlodipine reduced both blood pressure (from 164 ± 14/10 ± 6 mmHg to 134 ± 9/83 ± 4 mmHg) and left ventricular mass index (from 160 ± 30 g/m2 to 137 ± 26 g/m2) significantly at 3 months and both parameters maintained at these levels for 6 months. When the patients were classified according to the type of the LVH. a significant regression in left ventricular mass index was seen only in the patients who had concentric LVH with a relative wall thickness ≥ 0.44 (n = 16), but not in the eccentric LVH group (n = 14), although both groups were not significantly different from each other regarding the basal hemodynamic parameters. baseline left ventricular mass index and the decrease in blood pressure in response to amlodipine treatment. The mitral inflow E/A ratio did not show any significant change in either group.
Conclusions: Across the three chronic heart disease risk strata, lovastatin appears to be significantly more potent than fluvastatin, on a per milligram basis, in lowering cholesterol levels.
Get full access to this article
View all access options for this article.